協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2014/04/23 | 1,151 | 1,159 | 1,147 | 1,154 | +9 | +0.8% | 849,000 |
2014/04/22 | 1,157 | 1,163 | 1,145 | 1,145 | -5 | -0.4% | 739,000 |
2014/04/21 | 1,154 | 1,159 | 1,146 | 1,150 | ±0 | ±0% | 647,000 |
2014/04/18 | 1,145 | 1,151 | 1,140 | 1,150 | +5 | +0.4% | 694,000 |
2014/04/17 | 1,127 | 1,153 | 1,127 | 1,145 | +38 | +3.4% | 1,847,000 |
2014/04/16 | 1,085 | 1,112 | 1,085 | 1,107 | +28 | +2.6% | 1,256,000 |
2014/04/15 | 1,084 | 1,086 | 1,074 | 1,079 | +15 | +1.4% | 946,000 |
2014/04/14 | 1,061 | 1,082 | 1,060 | 1,064 | +4 | +0.4% | 1,187,000 |
2014/04/11 | 1,070 | 1,077 | 1,058 | 1,060 | -24 | -2.2% | 2,215,000 |
2014/04/10 | 1,085 | 1,089 | 1,071 | 1,084 | +16 | +1.5% | 1,488,000 |
2014/04/09 | 1,059 | 1,070 | 1,057 | 1,068 | -4 | -0.4% | 1,658,000 |
2014/04/08 | 1,080 | 1,080 | 1,057 | 1,072 | -15 | -1.4% | 1,362,000 |
2014/04/07 | 1,085 | 1,094 | 1,081 | 1,087 | -3 | -0.3% | 767,000 |
2014/04/04 | 1,085 | 1,090 | 1,075 | 1,090 | -9 | -0.8% | 1,132,000 |
2014/04/03 | 1,091 | 1,104 | 1,087 | 1,099 | +8 | +0.7% | 757,000 |
2014/04/02 | 1,097 | 1,100 | 1,085 | 1,091 | +13 | +1.2% | 1,293,000 |
2014/04/01 | 1,098 | 1,099 | 1,076 | 1,078 | -22 | -2% | 1,309,000 |
2014/03/31 | 1,097 | 1,103 | 1,085 | 1,100 | +3 | +0.3% | 976,000 |
2014/03/28 | 1,093 | 1,105 | 1,088 | 1,097 | +11 | +1% | 1,295,000 |
2014/03/27 | 1,064 | 1,089 | 1,064 | 1,086 | +32 | +3% | 2,092,000 |
2014/03/26 | 1,073 | 1,075 | 1,048 | 1,054 | +1 | +0.1% | 1,704,000 |
2014/03/25 | 1,050 | 1,073 | 1,046 | 1,053 | +9 | +0.9% | 1,645,000 |
2014/03/24 | 1,014 | 1,067 | 1,014 | 1,044 | +38 | +3.8% | 1,802,000 |
2014/03/20 | 1,024 | 1,029 | 1,006 | 1,006 | -23 | -2.2% | 963,000 |
2014/03/19 | 1,026 | 1,042 | 1,015 | 1,029 | +5 | +0.5% | 1,117,000 |
2014/03/18 | 1,021 | 1,036 | 1,020 | 1,024 | +11 | +1.1% | 803,000 |
2014/03/17 | 1,013 | 1,029 | 1,011 | 1,013 | -10 | -1% | 917,000 |
2014/03/14 | 1,040 | 1,048 | 1,020 | 1,023 | -45 | -4.2% | 2,949,000 |
2014/03/13 | 1,067 | 1,078 | 1,066 | 1,068 | -1 | -0.1% | 694,000 |
2014/03/12 | 1,089 | 1,091 | 1,069 | 1,069 | -37 | -3.3% | 978,000 |
2014/03/11 | 1,093 | 1,107 | 1,087 | 1,106 | +20 | +1.8% | 555,000 |
2014/03/10 | 1,090 | 1,105 | 1,082 | 1,086 | -18 | -1.6% | 884,000 |
2014/03/07 | 1,116 | 1,119 | 1,102 | 1,104 | -6 | -0.5% | 1,150,000 |
2014/03/06 | 1,086 | 1,116 | 1,075 | 1,110 | +24 | +2.2% | 1,271,000 |
2014/03/05 | 1,088 | 1,099 | 1,085 | 1,086 | +13 | +1.2% | 876,000 |
2014/03/04 | 1,061 | 1,083 | 1,059 | 1,073 | +3 | +0.3% | 946,000 |
2014/03/03 | 1,086 | 1,091 | 1,066 | 1,070 | -21 | -1.9% | 665,000 |
2014/02/28 | 1,101 | 1,106 | 1,085 | 1,091 | -9 | -0.8% | 660,000 |
2014/02/27 | 1,111 | 1,111 | 1,091 | 1,100 | -6 | -0.5% | 690,000 |
2014/02/26 | 1,090 | 1,110 | 1,087 | 1,106 | -1 | -0.1% | 524,000 |
2014/02/25 | 1,106 | 1,114 | 1,098 | 1,107 | +10 | +0.9% | 795,000 |
2014/02/24 | 1,079 | 1,107 | 1,077 | 1,097 | -12 | -1.1% | 1,155,000 |
2014/02/21 | 1,063 | 1,112 | 1,063 | 1,109 | +46 | +4.3% | 1,006,000 |
2014/02/20 | 1,089 | 1,090 | 1,059 | 1,063 | -10 | -0.9% | 1,098,000 |
2014/02/19 | 1,050 | 1,079 | 1,047 | 1,073 | +1 | +0.1% | 1,094,000 |
2014/02/18 | 1,045 | 1,079 | 1,045 | 1,072 | +31 | +3% | 1,050,000 |
2014/02/17 | 1,019 | 1,045 | 1,019 | 1,041 | +12 | +1.2% | 1,072,000 |
2014/02/14 | 1,048 | 1,058 | 1,024 | 1,029 | -25 | -2.4% | 1,858,000 |
2014/02/13 | 1,055 | 1,065 | 1,047 | 1,054 | +3 | +0.3% | 1,452,000 |
2014/02/12 | 1,054 | 1,060 | 1,044 | 1,051 | +7 | +0.7% | 1,117,000 |
2701~
2750
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 217,400円 | -3.5% | -11.3% | 2.76% | 19.97倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 135,300円 | +0.9% | +380.2% | 5.76% | 18.63倍 | 1.60倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 220,700円 | +20.9% | +10.6% | 2.99% | 10.43倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 388,100円 | +1.7% | -2.9% | 4.12% | 25.46倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 150,100円 | +0.6% | +43.3% | 5.33% | 10.52倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム